Related Experiment Video

Updated: Jul 13, 2026

Valorization of the Red Seaweed Gracilaria gracilis Through a Biorefinery Approach
10:18

Valorization of the Red Seaweed Gracilaria gracilis Through a Biorefinery Approach

Published on: November 21, 2023

Stictic acid derivatives from the lichen Usnea articulata and their antioxidant activities

Françoise Lohézic-Le Dévéhat1, Sophie Tomasi, John A Elix

  • 1Institut de Chimie de Rennes, EA 4090 Substances Lichéniques et Photoprotection, Faculté de Pharmacie, Université de Rennes, 2 Avenue du Professeur Léon Bernard, 35043 Rennes Cedex, France. francoise.le-devehat@univ-rennes1.fr

Journal of Natural Products
|July 17, 2007
PubMed

Related Concept Videos

Antifungal Agents01:15

Antifungal Agents

Amphotericin B is a broad-spectrum antifungal agent that exploits structural differences between fungal and mammalian cell membranes. Its amphipathic structure—featuring a hydrophobic polyene-lactone ring and a hydrophilic region containing mycosamine and carboxylic acid groups—enables selective binding to ergosterol, a sterol predominantly found in fungal plasma membranes. This selective interaction underlies the drug’s antifungal activity, although weak binding to cholesterol contributes to...
Radical Reactivity: Steric Effects01:10

Radical Reactivity: Steric Effects

The presence of electron-donating, electron-withdrawing, or conjugating groups adjacent to a radical center, imparts electronic stabilization to the radicals. Examples of such electronically-stabilized radicals are triphenylmethyl, tetramethylpiperidine‐N‐oxide, and 2,2‐diphenyl‐1‐picrylhydrazyl. These radicals are remarkably stable and are known as persistent radicals. Some of the persistent radicals can even be isolated and purified.
Along with electronic factors, steric factors also account...
Antiasthma Drugs: Leukotriene Modifiers01:19

Antiasthma Drugs: Leukotriene Modifiers

Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms: